Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
In HIV hypercholesterolemic patients treated with protease inhibitors, some drugs of the
statin group are used to control cholesterol level. New and potentially more efficient
statins may interfere with protease inhibitors and hence loose a part of their activity. They
have thus to be compared with a more established drug of the same class (e.g. pravastatin).
The protocol compares the efficacy and safety of rosuvastatin and pravastatin.
Phase:
Phase 4
Details
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Treatments:
Anti-Retroviral Agents HIV Protease Inhibitors Pravastatin Protease Inhibitors Rosuvastatin Calcium